NCT01883713View on ClinicalTrials.gov

Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Other Functional Disturbances Following Cardiac Surgery
Interventions
DEVICE

Brain Oximetry

Non invasive brain oximeter will be applied on the patient's forehead to monitor the brain oxygen saturation throughout the surgery.

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT01883713 - Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients | Biotech Hunter | Biotech Hunter